of the patent-in-suit. Sanofi and Regeneron defended the validity of the patent-in-suit against Amgen’s counterclaim for revocation by arguing, inter alia , that the subject-matter of the patent...

injunctive relief under Sec. 139 German Patent Act (PatG), on the qualified notification under Sec. 83 German Patent Act and on the protection of trade secrets during patent litigation. 1. Claim...

attempts by patent holders. A particular patent in a family may or may not be standard-essential, whereas other family members may be the opposite. Therefore, the register might include many pat...

infringement by the patent owner, the infringer has to clearly, unambiguously as well as genuinely and unconditionally declare its willingness to conclude a license agreement with the patent...

When it comes to litigating pharma patents, certain provisions and considerations apply that distinguish the enforcement of such patents from the enforcement of patents in other technical...

fair matters. In contrast to this, in matters under patent law, an ex parte injunction – in particular according to the case law of the important patent litigation courts of Düsseldorf and...

FRAND. The patent proprietor can make use of this range without, according to the judgment of the Higher Regional Court of Munich, the patent user’s counter-offer being crucial. For patent...

protection of succession pursuant to Sec. 15(3) German Patent Act, objections against the previous patent owner cannot be used as a defense against the new patent owner (marg. no. 131)....